Ebola vaccine developed in Canada shows promising results
by Press Release from Outbreak News Today on (#2TB4Q)
A phase 1 randomized controlled trial has found an Ebola virus disease (EVD) vaccine, developed in Canada, was well-tolerated with no safety concerns, and high antibodies were present in participants 6 months after immunization. The study, led by Canadian researchers, is published in CMAJ (Canadian Medical Association Journal). The research team conducted the clinical trial ["]
The post Ebola vaccine developed in Canada shows promising results appeared first on Outbreak News Today.